Endocrine evaluation of hypospadias

Advances in Experimental Medicine and Biology

Volumn 545, Issue , 2004, Pages 31-43

  Hyun, Grace ^a   Kolon, Thomas F ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; GESTAGEN; GLUTAMINE; MUELLERIAN INHIBITING FACTOR; ORAL CONTRACEPTIVE AGENT; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

CONFERENCE PAPER; ENDOCRINE FUNCTION; ENDOCRINE SYSTEM; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME DEFICIENCY; FERTILIZATION IN VITRO; GENE FUNCTION; GENE MUTATION; GENETIC DISORDER; GENITAL SYSTEM; HORMONE ACTION; HUMAN; HYPOSPADIAS; INHERITANCE; MALE; MALE PSEUDOHERMAPHRODITISM; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRILIZATION;

EID: 2342455778     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8995-6_3     Document Type: Conference Paper

References (58)

1. Aaronson, I.A., Cakmak, M.A., Key, L.L., 1997, Defects of the testosterone biosynthetic pathway in boys with hypospadias. J Urol, 157(5):1884-1888.
2. Aarskog, D., 1979, Current concepts: maternal progestins as a possible cause of hypospadias. N Engl J Med, 300:75-78.
3. Allen, T.D. and Griffin, J.E., 1984, Endocrine studies in patients with advanced hypospadias. J Urol, 131:310-314.
4. Allera, A., Herbst, M.A., Griffin, J.E. et al., 1995, Mutations of the AR gene coding sequence are infrequent in patients with isolated hypospadias. J Clin Endocrinol Metab, 80:2697-9.
5. Andersson, S., 1995, 17 beta hydroxysteroid dehydrogenase: isozymes and mutations. J Endocrinol, 146:197-200.
6. Angerpointer, T., 1984, Hypospadias- Genetics, epidemiology and other possible aetiological influences. Z Kinderchir, 39:112-118.
7. Austin, P.F., Siow, Y., Fallat, M.E., et al., 2002, The Relationship Between Müllerian Inhibiting Substance and Androgens in Boys with Hypospadias. J Urol, 168:1784-1788.
8. Bauer, S.B., Retik, A.B., and Colodny, A.H., 1981, Genetic aspects of hypospadias. Urol Clin North Am, 8:559-564.
9. Bjerkedal, T. and Bakketeig, L.S., 1975, Surveillance of congenital malformations and other conditions of the new born. Int J Epidemiol, 4:31-36.
10. Calzolari, E., Contrero, M.R., Roncarati, E., et al., 1986, Aetiological factors in hypospadias. J Med Genet, 23:333-337.
11. Can, S., Zhu, Y-S, Cai, L-Q, et al., 1998, The identification of 5_ reductase 2 and 17_ hydroxysteroid dehydrogenase 3 gene defects in male pseudohermaphrodites from a Turkish kindred. J Clin Endocrinol Metab, 83:560-569.
12. Casella, R., Kolon, T.F., Maduro, M., et al., CAG repeat length in exon 1 of the androgen receptor gene of patients with cryptorchidism and/or hypospadias. Presented at annual meeting of Section on Urology, American Academy of Pediatrics, San Francisco, California, October 20-22, 2001.
13. Castro-Magana, M., Angulo, M., and Uly, J., 1993, Male hypogonadism with gynecomastia caused by late-onset deficiency of testicular 17-ketosteroid reductase. N Engl J Med, 328:1297-1301.
14. Clark, R., Antonello, J., Grossman, S., et al., 1990, External genitalia abnormalities in male rats exposed in utero to finasteride, a 5α reductase inhibitor. Teratology; 42:91-100.
15. Clark, R., Antonello, J., Grossman, S., et al., 1993, Critical developmental periods for effects on male rat genitalia induced by finasteride, a 5α reductase inhibitor. Toxicol Appl Pharmacol, 119:34-40.
16. Czeizel, A., Toth, J. and Erodi, E., 1979, Aetiological studies of hypospadias in Hungary. Hum Hered, 38:45-50.
17. Czeizel, A., 1985, Increasing trends in congenital malformations of male external genitalia. Lancet, 1:462-463.
18. Dean, H.J. and Winter, J.S., 1984, The effect of five synthetic progestational compounds on 5 alpha reductase activity in genital skin fibroblast monolaYERS. Steroids, 43:13-17.
19. Dolk, H., 1998, Rise in the prevalence of hypospadias. Lancet, 351:770.
20. th ed. Philadelphia, PA: W. B. Saunders Co., vol. 2, chapt. 68, 2093-2119
21. Feyaerts, A., Forest, M.G., Morel, Y., et al., 2002, Endocrine Screening in 32 Consecutive Patients with Hypospadias. J Urol, 168:720-725.
22. Fredell, L., Iselius, L., Collins, A. et al., 2002, Complex segregation analysis of hypospadias. Hum Genet, 111:231-234.
23. Gearhart, J.P., Linhard, H.R., Berkovitz, G.D. et al., 1988, Androgen receptor levels and 5 alpha-raductase activities in preputial skin and chordee tissue of boys with isolated hypospadias. J Urol, 140(5 pt 2):1243-1246.
24. Geissler, W.M., Davis, D.L., Wu, L., et al., 1994, Male pseudohermaphroditism caused by mutations of testicular 17 beta hydroxysteroid dehydrogenase3. Nat Genet, 7:34-39.
25. th Ed, Vol II, McGraw-Hill, NY, 1989:1919-1944.
26. Goldman, A.S. and Bongiovanni, A.M., 1967, Induced genital anomalies. Ann NY Acad Sci, 142:755-767.
27. Hakimi, J.M., Rondinelli, R.H., Schenberg, M.P., et al., 1996, Androgen receptor gene structure and function in prostate cancer. World J Urol, 14:329-337.
28. Hiort, O., Willenbring, H., Albers, N., et al., 1996, Molecular genetic analysis and human chorionic gonadotropin stimulation tests in the diagnosis of prepubertal patients with partial 5 alpha reductase deficiency. Eur J Pediatr, 155:445-451.
29. Holmes, N.M., Miller, W.L. and Baskin, L.S., Defects in androgen production as a role in the etiology of hypospadias. Presented at annual meeting of Section on Urology, American Academy of Pediatrics, San Francisco, California, October 20-22, 2001.
30. Imperato-McGinley, J., Miller, M., Wilson, J., et al., 1991, A cluster of male pseudohermaphrodites with 5α reductase deficiency in Papua New Guinea. Clin Endocrinol, 34:293-298.
31. Kallen, B. and Winberg, J., 1982, An epidemiological study of hypospadias in Sweden. Acta Paediatr Scand Suppl, 293:3-21.
32. Kallen, B., Bertolini, R., Castilla, A., et al., 1986, A joint international study on the epidemiology of hypospadias. Acta Paediatr Scand Suppl, 324:1-52.
33. Kim, K.S., Liu, W., Cunha, G.R., et al., 2002, Cell Tissue Res., 307(2):145-53. Epub 2001 Nov 27.
34. Knorr, D., 1979, Plasma testosterone in male puberty. II. hCG stimulation test in boys with hypospadias. Acta Endocrinol (Copenh), 90:365.
35. Kohn, G., Lasch, E.E., El-Shawwa, R., et al., 1985, Male pseudohermaphroditism due to 17-beta hydroxysteroid dehydrogenase deficiency in a large Arab kinship: studies on the natural history of the defect. J Pediatr Endocr, 1:29-37.
36. Kolon, T.F., Murthy, L., Gonzales, E.T., Jr., et al., Prevalence of intersex in hypospadias and cryptorchidism. Presented at annual meeting of Section on Urology, American Academy of Pediatrics, San Francisco, California, October 20-22, 2001.
37. MacLean, H.E., Warne, G.L., and Zajac, J.D., 1995, Defects of androgen receptor function: from sex reversal to motor neurone disease. Molec Cell Endocrinol, 112:133-141.
38. Matlai, P. and Beral, V., 1985, Trends in congenital malformations of external genitalia. Lancet, 1:108.
39. Mau, G., 1981, Progestins during pregnancy and hypospadias. Teratology, 24:285-287.
40. Monteleone, N.R., Castilla, E.F. and Paz, J.E., 1981, Hypospadias: An epidemiologic study in Latin America. Am J Med Genet, 10:5-19.
41. Nonomura, K., Fujieda, K., Sakakibara, N. et al., 1984, Pituitary and gonadal function in prepubertal boys with hypospadias. J Urol, 132:595-598.
42. North, K. and Golding, J., 2000, A maternal vegetarian diet in pregnancy is associated with hypospadias. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. BJU Int., 85(1):107-13.
43. Paulozzi, L.J., Erickson, D.J., and Jackson, R.J., 1997, Hypospadias trends in two American surveillance systems. Pediatrics, 100:831-834.
44. Prahalada, S., Tarantal, A.F., Harris, G.S., et al., 1997, Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta). Teratology. Feb 55(2):119-31.
45. Raman-Wilms, L., Tseng, A., Wighardt, S., et al., 1995, Fetal genital effects of first tri85 imester sex hormone exposure: a meta-analysis. Obstet Gynecol, 141-149.
46. Rosler, A., 1992, Steroid 17 beta hydroxysteroid dehydrogenase in man: an inherited form of male pseudohermaphroditism. J Steroid Biochem Mol Biol, 43:989-1002.
47. Russell, D.W. and Wilson, J.D., 1994, Steroid 5 alpha reductase: two genes/two enzymes. Ann Rev Biochem, 63:25-61.
48. Shima, H., Ikoma, F., Yabumoto, H., et al., 1986, Gonadotropin and testosterone response in prepubertal boys with hypospadias. J Urol, 135:539-542.
49. Shima, H., Yabumoto, H., Okamoto, E., et al., 1992, Testicular function in patients with hypospadias associated with enlarged prostatic utricle. Br J Urol, 69:192-195.
50. Siiteri, P. and Wilson, J., 1974, Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab, 38:113-124.
51. Silver, R.I. and Russell, D.W., 1999, 5-reductase type 2 mutations are present in some boys with isolated hypospadias. J Urol, 162:1142-1145.
52. Silver, R.I., Rodriguez, R., Chang, T.S., et al., 1999, In vitro fertilization is associated with an increased risk of hypospadias. J Urol, 161:1954-1957.
53. Sinnecker, G.H., Hiort, O., Dibbelt, L., et al., 1996, Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha reductase 2 deficiency. Am J Med Genet, 63:223-230.
54. Sorenson, H.R. 1953, Hypospadias with special reference to aetiology. Copenhagen, Munksgaard, 94.
55. Sutherland, R.W., Weiner, J.S., Hicks, J.P., et al., 1996, Androgen receptor gene mutations are rarely associated with isolated penile hypospadias. J Urol, 156:828-831.
56. Sweet, Ra, Schrott, H.G., Kurland, R., et al., 1974, Study of the incidence of hypospadias in Rochester, Minnesota 1940-1970 and a case control comparison of possible etiologic actors. Mayo Clin Proc, 49:52-57.
57. Thigpen, A., Davis, D., and Milatovich, A., 1992, Molecular genetics of steroid 5 alpha reductase deficiency. J Clin Invest, 90:799-809.
58. Thigpen, A., Silver, R., Guileyardo, J., et al., 1993, Tissue distribution and ontogeny of steroid 5 alpha reductase isozyme expression. J Clin Invest, 92:903-910.